Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
TAK
TAK: Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.
moreShow TAK Financials
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of TAK by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TAK's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
-
Patent Title: Antibodies which bind fc receptors (fcrn) Aug. 29, 2023
-
Patent Title: Production method of thienopyrimidine derivative Aug. 22, 2023
-
Patent Title: Antibody drug conjugates Aug. 15, 2023
-
Patent Title: Heterocyclic compound Aug. 01, 2023
-
Patent Title: Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a Jul. 25, 2023
-
Patent Title: Heterocyclic compound and use thereof Jul. 18, 2023
-
Patent Title: Preparation comprising vonoprazan Jul. 11, 2023
-
Patent Title: Affinity purification of glycosidase-cleaving enzymes Jun. 27, 2023
-
Patent Title: Pooling device for single or multiple medical containers Jun. 27, 2023
-
Patent Title: Maribavir isomers, compositions, methods of making and methods of using Jun. 27, 2023
-
Patent Title: Single domain antigen binding domains that bind human trop2 Jun. 27, 2023
-
Patent Title: Fluid delivery device Jun. 13, 2023
-
Patent Title: Use of adipose tissue-derived stromal stem cells in treating fistula Jun. 13, 2023
-
Patent Title: Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk Jun. 06, 2023
-
Patent Title: Method and apparatus for providing a pharmacokinetic drug dosing regiment Jun. 06, 2023
-
Patent Title: Antibody-drug conjugates comprising a cyclic dinucleotide Jun. 06, 2023
-
Patent Title: Methods of purifying recombinant adamts13 and other proteins and compositions thereof May. 30, 2023
-
Patent Title: Use of adipose tissue-derived stromal stem cells in treating fistula May. 30, 2023
-
Patent Title: Glp-2 analogs and peptibodies for administration before, during or after surgery May. 30, 2023
-
Patent Title: Heterocyclic compound and use thereof May. 23, 2023
-
Patent Title: Alginate hydrogel compositions May. 23, 2023
-
Patent Title: Method for producing pyrrole compound May. 16, 2023
-
Patent Title: Method of predicting a performance characteristic of a plant or yeast hydrolysate and its use May. 16, 2023
-
Patent Title: Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies Mar. 28, 2023
-
Patent Title: Syringe screening device Mar. 28, 2023
-
Patent Title: Predicting outcome of treatment with an anti-α4β7 integrin antibody Mar. 07, 2023
-
Patent Title: Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs Mar. 07, 2023
-
Patent Title: Gene therapy of hemophilia b using viral vectors encoding recombinant fix variants with increased expression Mar. 07, 2023
-
Patent Title: Heterocyclic compound Feb. 21, 2023
-
Patent Title: Adeno-associated virus formulations Feb. 21, 2023
-
Patent Title: Formulation of an antibody and use thereof Feb. 14, 2023
-
Patent Title: Compositions and methods for treating gaucher disease Feb. 07, 2023
-
Patent Title: Nucleophilic catalysts for oxime linkage Jan. 31, 2023
-
Patent Title: Stabilized liquid and lyophilized adamts13 formulations Jan. 31, 2023
-
Patent Title: Smart tourniquet Jan. 31, 2023
-
Patent Title: Heterocyclic compounds useful as modulators of acetylcholine receptors Jan. 24, 2023
-
Patent Title: Sting modulator compounds, and methods of making and using Jan. 03, 2023
-
Patent Title: Compositions comprising iduronate-2-sulfatase Dec. 20, 2022
-
Patent Title: Treatment of gastrointestinal bleeding in patients with severe von willebrand disease by administration of recombinant vwf Dec. 20, 2022
-
Patent Title: Process for the synthesis of 2-[(2s)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1h-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-one Dec. 13, 2022
-
Patent Title: Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases Nov. 29, 2022
-
Patent Title: Methods of detecting plasma kallikrein Nov. 22, 2022
-
Patent Title: Process for producing pyrrole compound Nov. 15, 2022
-
Patent Title: Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a Nov. 08, 2022
-
Patent Title: Document creation assistance server and document creation assistance method Nov. 08, 2022
-
Patent Title: Display library process Oct. 25, 2022
-
Patent Title: Non-adult human dosing of brentuximab vedotin Oct. 11, 2022
-
Patent Title: Mglur7 agonist compounds for treating mglur7-regulated diseases, disorders, or conditions Oct. 11, 2022
-
Patent Title: Heterocyclic compound Oct. 04, 2022
-
Patent Title: Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation Oct. 04, 2022
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on TAK's company Twitter account
WallStreetBets
Number of mentions of TAK in WallStreetBets Daily Discussion
TAK News
Recent insights relating to TAK
CNBC Recommendations
Recent picks made for TAK stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in TAK
Corporate Flights
Flights by private jets registered to TAK